drugset / Trial / NCT00055198
Daptomycin for the Treatment of Infections Due to Gram-Positive Bacteria
Non-randomizedOpen-labelTreatment
Summary
The purpose of this study is to provide daptomycin, an antibiotic, to patients who are failing conventional therapy, or who cannot take approved antibiotics for one reason or another.
Timeline
- Start
- 2002-12-19
- Primary completion
- 2004-01-26
- Completion
- 2004-01-26
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Daptomycin | Other / unclassified | — | — |